Lv11
30 积分 2024-03-05 加入
Targeting HER3 to overcome EGFR TKI resistance in NSCLC
2小时前
待确认
Epidermal growth factor receptor: Role in human cancer
2小时前
已完结
BRIQUILIMAB POTENTLY INHIBITS STEM CELL FACTOR (SCF)/C-KIT SIGNALING, AND MAST CELL (MC) DEGRANULATION AND SURVIVAL
14天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
1个月前
已完结
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
1个月前
已完结
A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4
1个月前
已完结
ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases
2个月前
已完结
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
2个月前
已完结
Translational Investigation of CM326 from Preclinical Studies to Randomized Phase I Clinical Trials in Healthy Adults
2个月前
已完结
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
4个月前
已完结
皖公网安备34019202002308
